Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study.

van Os J, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome Investigators (GROUP), Arango C, O'Donovan M, Rutten BPF, Guloksuz S.

Psychol Med. 2019 Aug 15:1-14. doi: 10.1017/S003329171900196X. [Epub ahead of print]

PMID:
31414981
2.

Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.

Ferraro L, La Cascia C, Quattrone D, Sideli L, Matranga D, Capuccio V, Tripoli G, Gayer-Anderson C, Morgan C, Sami MB, Sham P, de Haan L, Velthorst E, Jongsma HE, Kirkbride JB, Rutten BPF, Richards AL, Roldan L, Arango C, Bernardo M, Bobes J, Sanjuan J, Santos JL, Arrojo M, Tarricone I, Tortelli A, Szöke A, Del-Ben CM, Selten JP, Lynskey M, Jones PB, Van Os J, La Barbera D; WP2 EU-GEI GROUP , Murray RM, Di Forti M.

Schizophr Bull. 2019 Jul 29. pii: sbz077. doi: 10.1093/schbul/sbz077. [Epub ahead of print]

PMID:
31361020
3.

Cognitive functioning in patients with alcohol use disorder who start outpatient treatment.

Villa R, Espandian A, Sáiz PA, Astals M, Valencia JK, Martínez-Santamaría E, Álvarez S, García-Portilla MP, Bobes J, Flórez G.

Adicciones. 2019 Jul 9;0(0):1326. doi: 10.20882/adicciones.1326. [Epub ahead of print] English, Spanish.

4.

Relevant risk factors of repeated suicidal attempts in a sample of outpatients.

Espandian A, González M, Reijas T, Florez G, Ferrer E, Saiz PA, Salgado-Barreira A, González A, Brenlla J, Docasar L, Bobes J.

Rev Psiquiatr Salud Ment. 2019 May 18. pii: S1888-9891(19)30047-3. doi: 10.1016/j.rpsm.2019.03.003. [Epub ahead of print] English, Spanish.

PMID:
31113750
5.

Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study.

Guloksuz S, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran E, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşog Lu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O'Donovan M, Rutten BPF, van Os J.

World Psychiatry. 2019 Jun;18(2):173-182. doi: 10.1002/wps.20629.

6.

Factors associated with tobacco consumption in patients with depression.

Jiménez-Treviño L, Velasco Á, Rodriguez-Revuelta J, Abad I, De la Fuente-Tomás L, González-Blanco L, García-Álvarez L, Fernández-Peláez A, Menéndez-Miranda I, Flórez G, García-Portilla P, Bobes J, Sáiz PA.

Adicciones. 2019 Mar 29;0(0):1191. doi: 10.20882/adicciones.1191. [Epub ahead of print] English, Spanish.

7.

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.

Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM; EU-GEI WP2 Group.

Lancet Psychiatry. 2019 May;6(5):427-436. doi: 10.1016/S2215-0366(19)30048-3. Epub 2019 Mar 19.

8.

Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population.

Jiménez E, Bonnín CDM, Solé B, Sánchez-Moreno J, Reinares M, Torrent C, Torres I, Salagre E, Varo C, Ruíz V, Giménez A, Benabarre A, Gutiérrez-Rojas L, Cervilla J, Sáiz PA, García-Portilla MP, Bobes J, Amann BL, Martínez-Arán A, Vieta E.

J Affect Disord. 2019 Apr 15;249:199-207. doi: 10.1016/j.jad.2019.02.037. Epub 2019 Feb 12.

PMID:
30772748
9.

Clinical implications of cognitive impairment and alcohol dependence.

Flórez G, Espandian A, Villa R, Sáiz PA.

Adicciones. 2019 Jan 1;31(1):3-7. doi: 10.20882/adicciones.1284. English, Spanish.

10.

Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia.

Gonzalez-Blanco L, Maria P Garcia-Portilla, Garcia-Alvarez L, Lorena de la Fuente-Tomas, Garcia CI, Pilar A Saiz, Julio Bobes.

Psychiatry Res. 2018 Nov;269:688-691. doi: 10.1016/j.psychres.2018.08.042. Epub 2018 Aug 17.

PMID:
30273893
11.

Novel validity evidence of the Psychopathy Checklist- Revised (PCL-R) in a representative sample of Spanish inmates.

Flórez G, Ferrer V, García LS, Crespo MR, Pérez M, Saiz PA, Cooke DJ.

Forensic Sci Int. 2018 Oct;291:175-183. doi: 10.1016/j.forsciint.2018.08.031. Epub 2018 Sep 1.

PMID:
30216843
12.

Bi-directional longitudinal associations between different types of bullying victimization, suicide ideation/attempts, and depression among a large sample of European adolescents.

Brunstein Klomek A, Barzilay S, Apter A, Carli V, Hoven CW, Sarchiapone M, Hadlaczky G, Balazs J, Kereszteny A, Brunner R, Kaess M, Bobes J, Saiz PA, Cosman D, Haring C, Banzer R, McMahon E, Keeley H, Kahn JP, Postuvan V, Podlogar T, Sisask M, Varnik A, Wasserman D.

J Child Psychol Psychiatry. 2019 Feb;60(2):209-215. doi: 10.1111/jcpp.12951. Epub 2018 Jul 19.

PMID:
30024024
13.

Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables.

Sanchez-Moreno J, Bonnin CM, González-Pinto A, Amann BL, Solé B, Balanzá-Martinez V, Arango C, Jiménez E, Tabarés-Seisdedos R, Garcia-Portilla MP, Ibáñez A, Crespo JM, Ayuso-Mateos JL, Martinez-Aran A, Torrent C, Vieta E; CIBERSAM Functional Remediation Group.

Acta Psychiatr Scand. 2018 Aug;138(2):145-154. doi: 10.1111/acps.12894. Epub 2018 May 3.

PMID:
29726004
14.

Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?

González-Blanco L, García-Portilla MP, García-Álvarez L, de la Fuente-Tomás L, Iglesias García C, Sáiz PA, Rodríguez-González S, Coto-Montes A, Bobes J.

Rev Psiquiatr Salud Ment. 2019 Jan - Mar;12(1):9-16. doi: 10.1016/j.rpsm.2018.03.004. Epub 2018 Apr 30. English, Spanish.

PMID:
29724678
15.

Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia.

González-Blanco L, García-Portilla MP, García-Álvarez L, de la Fuente-Tomás L, Iglesias García C, Sáiz PA, Rodríguez-González S, Coto-Montes A, Bobes J.

Rev Psiquiatr Salud Ment. 2018 Jul - Sep;11(3):130-140. doi: 10.1016/j.rpsm.2018.03.003. Epub 2018 Apr 22. English, Spanish.

PMID:
29691142
16.

Clinician ratings of the Comprehensive Assessment of Psychopathic Personality (CAPP) in a representative sample of Spanish prison inmates: New validity evidence.

Flórez G, Ferrer V, García LS, Crespo MR, Pérez M, Saíz PA, Cooke DJ.

PLoS One. 2018 Apr 12;13(4):e0195483. doi: 10.1371/journal.pone.0195483. eCollection 2018.

17.

A cost-effectiveness analysis of school-based suicide prevention programmes.

Ahern S, Burke LA, McElroy B, Corcoran P, McMahon EM, Keeley H, Carli V, Wasserman C, Hoven CW, Sarchiapone M, Apter A, Balazs J, Banzer R, Bobes J, Brunner R, Cosman D, Haring C, Kaess M, Kahn JP, Kereszteny A, Postuvan V, Sáiz PA, Varnik P, Wasserman D.

Eur Child Adolesc Psychiatry. 2018 Oct;27(10):1295-1304. doi: 10.1007/s00787-018-1120-5. Epub 2018 Feb 14.

PMID:
29442231
18.

Mental health difficulties and suicidal behaviours among young migrants: multicentre study of European adolescents.

McMahon EM, Corcoran P, Keeley H, Cannon M, Carli V, Wasserman C, Sarchiapone M, Apter A, Balazs J, Banzer R, Bobes J, Brunner R, Cozman D, Haring C, Kaess M, Kahn JP, Kereszteny A, Bitenc UM, Nemes B, Poštuvan V, Sáiz PA, Sisask M, Tubiana A, Värnik P, Hoven CW, Wasserman D.

BJPsych Open. 2017 Nov 30;3(6):291-299. doi: 10.1192/bjpo.bp.117.005322. eCollection 2017 Nov.

19.

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.

Pérez V, Salavert A, Espadaler J, Tuson M, Saiz-Ruiz J, Sáez-Navarro C, Bobes J, Baca-García E, Vieta E, Olivares JM, Rodriguez-Jimenez R, Villagrán JM, Gascón J, Cañete-Crespillo J, Solé M, Saiz PA, Ibáñez Á, de Diego-Adeliño J; AB-GEN Collaborative Group, Menchón JM.

BMC Psychiatry. 2017 Jul 14;17(1):250. doi: 10.1186/s12888-017-1412-1.

20.

Suicide, unemployment, and economic recession in Spain.

Iglesias-García C, Sáiz PA, Burón P, Sánchez-Lasheras F, Jiménez-Treviño L, Fernández-Artamendi S, Al-Halabí S, Corcoran P, García-Portilla MP, Bobes J.

Rev Psiquiatr Salud Ment. 2017 Apr - Jun;10(2):70-77. doi: 10.1016/j.rpsm.2016.04.005. Epub 2017 Feb 24. English, Spanish.

PMID:
28238615

Supplemental Content

Loading ...
Support Center